TipRanks
Enlivex Therapeutics Ltd (DE:1BT)
FRANKFURT:1BT
Germany Market
1BT
Enlivex
RESEARCH TOOLSreports

Enlivex (1BT) Income Statement

0 Followers

Enlivex Income Statement

Last quarter (Q2 2026), Enlivex's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, Enlivex's net income was $1.89B. See Enlivex’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Mar 23Mar 22
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -332.00K$ -545.00K$ -835.00K$ -777.00K$ -546.00K
Operating Expenses
$ 14.67M$ 14.99M$ 29.39M$ 25.80M$ 19.29M
Depreciation and Amortization
$ 332.00K$ 545.00K$ 835.00K$ 777.00K$ 546.00K
EBITDA
$ -14.67M$ -14.47M$ -28.22M$ -25.02M$ -18.74M
Operating Income
$ -15.00M$ -15.54M$ -29.39M$ -25.80M$ -19.29M
Other Income/Expenses
$ 1.63B$ 522.00K$ 327.00K$ -5.26M$ 4.82M
Pretax Income
$ 1.62B$ -15.01M$ -29.07M$ -31.06M$ -14.47M
Net Income
$ 1.24B$ -15.01M$ -29.07M$ -31.06M$ -14.47M
Per Share Metrics
Basic EPS
$ 405.60$ -10.95$ -23.40$ -34.65$ -8.10
Diluted EPS
$ 382.20$ -10.95$ -23.40$ -34.65$ -8.10
Weighted Average Shares Outstanding
 3.05M 1.37M 1.24M 1.23M 1.19M
Weighted Average Shares Outstanding (Diluted)
 3.23M 1.37M 1.24M 1.23M 1.19M
Currency in USD

Enlivex Earnings and Revenue History